Rocket Pharmaceuticals, Inc. (RCKT) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Rocket Pharmaceuticals, Inc. (RCKT) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

RCKT Cash Flow Statement

Rocket Pharmaceuticals, Inc. (RCKT) cash flow statement — 14-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-39.61M	-45.39M	-34.84M	-50.43M	-48.96M	-55.8M	-46.96M	-52.1M	-53.85M	-56.88M	-29.37M	-57.15M	-50.87M	-57.6M	-56.06M	-43.86M	-39.04M	-39.27M	-30.94M	-27.87M
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	19.1%	18.65%	25.8%	3.21%	9.08%	1.9%	-59.89%	8.83%	-5.86%	1.24%	47.61%	-30.3%	-30.3%	-46.68%	-81.18%	-57.35%	1.85%	-62.13%	-136.03%	-61.55%
Net Income	123.21M	-47.59M	-42.54M	-50.33M	-68.92M	-61.33M	-60.33M	-66.72M	-69.65M	-62.05M	-59.66M	-61.9M	-65.7M	-58.34M	-66.72M	-57.76M	-54.4M	-42.98M	-44.25M	-50.12M
Depreciation & Amortization	2.1M	2.15M	2.22M	3.24M	2.58M	2.99M	2.36M	2.42M	2.37M	2.25M	2.37M	1.76M	1.73M	1.67M	1.78M	1.08M	496K	1.3M	3.19M	800K
Stock-Based Compensation	7.42M	8.49M	6.11M	9.76M	10.86M	10.33M	11.09M	11.25M	11.33M	10.25M	0	10.32M	10.24M	8.91M	0	7.68M	7.37M	6.27M	7.04M	0
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	12.47M	0	0	0	0	0	0	0	0
Other Non-Cash Items	-178.83M	-1.02M	-826K	-1.6M	-2.21M	-2.08M	653K	699K	-2.24M	-2.75M	6.43M	-13.85M	-2.49M	-2.34M	8.75M	690K	1.61M	617K	6.26M	15.37M
Working Capital Changes	6.48M	-7.42M	195K	-11.5M	8.73M	-5.71M	-732K	248K	4.33M	-4.58M	21.5M	-5.94M	5.34M	-7.51M	132K	4.45M	5.89M	-4.47M	-3.18M	6.08M
Change in Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	5.75M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.55M	0	0	0
Cash from Investing	214.36M	17.45M	36.42M	93.62M	31.76M	-58.03M	-37.87M	78.92M	55.62M	35.03M	-140.81M	48.25M	31.21M	-36.72M	-108.58M	23.46M	78.79M	-62.99M	16.86M	-18.19M
Capital Expenditures	-8K	-93K	-80K	54K	-50K	-364K	-309K	-1.59M	-1.93M	-2.04M	-4.65M	-4.66M	-4.15M	-3.02M	-3.26M	-503K	-2.9M	-1.96M	-2.79M	-3.84M
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	-52.91K	-35.33K	0	42.73M	-23.97K	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	178.19M	0	0	0	0	0	0	0	0	0	0	52.91K	35.33K	0	0	23.97K	143.02M	0	748K	0
Cash from Financing	150K	-1K	0	-59K	215K	12K	182.86M	176K	1.56M	1.21M	421K	189.49M	182K	18.38M	108.48M	29.53M	17.25M	121K	1.14M	27.1M
Debt Issued (Net)	0	-1K	0	8K	13K	12K	15K	24K	29K	27K	30K	35K	0	37K	38K	0	0	45K	0	460K
Equity Issued (Net)	152K	0	0	0	215K	0	182.85M	176K	1.53M	1.18M	391K	189.49M	182K	18.34M	108.44M	29.53M	17.25M	76K	-10.19M	26.64M
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-47K	0	0	0	0	0
Other Financing	-2K	0	0	-67K	-13K	0	0	-24K	0	0	0	-35K	0	0	0	0	0	0	11.33M	0
Net Change in Cash	174.9M	-27.95M	1.58M	43.13M	-16.99M	-113.83M	98.04M	26.99M	3.33M	-20.63M	-169.75M	180.59M	-19.48M	-75.94M	-56.15M	9.13M	57M	-102.14M	-12.94M	-18.96M
Free Cash Flow	-39.62M	-45.49M	-34.92M	-50.37M	-49.01M	-56.17M	-47.27M	-53.69M	-55.78M	-58.92M	-34.02M	-61.8M	-55.02M	-60.62M	-59.32M	-44.36M	-41.94M	-41.22M	-32.98M	-31.71M
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	19.16%	19.01%	26.12%	6.18%	12.13%	4.67%	-38.95%	13.13%	-1.39%	2.81%	42.66%	-39.32%	-31.19%	-47.05%	-79.86%	-39.89%	-1.59%	-67.93%	-17.67%	-49.74%
FCF per Share	-0.35	-0.41	-0.31	-0.45	-0.44	-0.51	-0.48	-0.57	-0.60	-0.63	-0.36	-0.75	-0.68	-0.76	-0.81	-0.67	-0.64	-0.64	-0.51	-0.50
FCF Conversion (FCF/Net Income)	-0.32x	0.95x	0.82x	1.00x	0.71x	0.91x	0.78x	0.78x	0.77x	0.92x	0.49x	0.92x	0.77x	0.99x	0.84x	0.76x	0.72x	0.91x	0.70x	0.56x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0